NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘New Enterprise Associates’

26 March 2015

NEA eyes record $2.75bn Fund XV close

money funnel tunnel dollars US venture capital major New Enterprise Associates has reportedly raised close to $2.57bn towards its $2.75bn-targeting fifteenth fund.

18 March 2015

Founders Fund, NEA co-lead $38m round in Collective Health

healthcare Founders Fund and New Enterprise Associates have a co-led a $38m Series B financing round in self-insurance platform provider Collective Health.

17 March 2015

NEA in $30m Series B for app company FiftyThree

news_apps_lrg Venture capital major New Enterprise Associates (NEA) has taken part in a $30m Series B round for ‘mobile tools’ app maker FiftyThree.

13 March 2015

NEA, Hatteras reup in PhaseBio through $40m Series C round

heart_lrg New Enterprise Associates and Hatteras Venture Partners have renewed their commitment to PhaseBio Pharmaceuticals through a $40m Series C round.

12 March 2015

AstraZeneca leads $40m Series C for once-a-week insulin developer PhaseBio

injection_lrg Pharmaceutical giant AstraZeneca has headed up a $40m investment round for metabolic and cardiopulmonary specialist PhaseBio Pharmaceuticals.

2 March 2015

NEA leads $35m Series B round in Mersana Therapeutics

download (56) Existing investor New Enterprise Associates (NEA) has led a $35m Series B-1 financing round in Massachusetts-based Mersana Therapeutics.

20 February 2015

Illinois Teachers backs RRJ, Carlyle Japan amid $900m of new commitments

chicago illinois_sq The $44.8bn Illinois Teachers Retirement System (TRS) has backed RRJ Capital’s latest Asia fund amid $900m of new commitments.

19 February 2015

Sequoia, Redpiont and Enterprise lead $34m round in Springpath

data-centre-416230-m A trio of venture capital investors have led a $34m round in Springpath, a provider of enterprise-grade storage and data management software.

28 January 2015

VC-backed Zosano Pharma launches IPO

Pharmedium drugs Venture capital-backed biopharmaceutical company Zosano Pharma has launched for an Intial public offering, pricing its 4.5 million shares at $11 per share.

22 January 2015

NEA leads $56m Series B round for online gift card company Raise

Raise gift card US venture capital major New Enterprise Associates has led a $56m Series B financing round for online gift card marketplace Raise.

Page 1 of 1112345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015